HOME >> BIOLOGY >> NEWS
Surprises found in gene variation associated with schizophrenia

Approximately 2 percent of Caucasians have a gene segment variation that can cause a certain form of schizophrenia. Most people with the variation, known as a polymorphism, do not have the disease. A University of Iowa Health Care study reveals a good prognosis for people who do have this form of schizophrenia. The team also found that this polymorphism is associated with overall benefits for human survival, and the initial mutation occurred in a single common ancestor about 100,000 years ago.

The findings have implications for finding better ways to treat this particular type of schizophrenia and possibly augmenting the positive influences of the polymorphism on human survival. The findings also point the way for studying other gene defects. The UI Research Foundation and the National Institutes of Health (NIH) share a patent for this X-chromosome gene polymorphism, known as HOPA12pb. The study results appeared in the February 11 online issue of the American Journal of Medical Genetics.

"While this polymorphism makes us more vulnerable to a certain illness, in this case schizophrenia, overall it is evolutionarily beneficial," said Robert Philibert, M.D., Ph.D., UI associate professor of psychiatry in the Roy J. and Lucille A. Carver College of Medicine and the study's principal investigator.

"Traditionally, genes that are selected for human evolution affect two things -- resistance to infection and infant survival. This gene may be involved in both of these positive features," Philibert added.

While nearly one in 50 people of European extraction has the HOPA polymorphism, only a small minority of people with the variant gene sequence actually have schizophrenia. About one in 30 men with the particular polymorphism has the condition. Men are more likely than women to have this form of schizophrenia because the gene is X-chromosome linked.

People with HOPA-link
'"/>

Contact: Becky Soglin
becky-soglin@uiowa.edu
319-335-6660
University of Iowa
12-Apr-2004


Page: 1 2

Related biology news :

1. Bacterial Toxin Surprises Scientists
2. New signs of life found at the Poles
3. Key cell-death step found
4. European common frog found to use novel mating strategy
5. Byproduct of water-disinfection process found to be highly toxic
6. Genuine stem cells found in skin might treat hair loss, wounds
7. Flame retardants found on supermarket shelves
8. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
9. Genetic clues found for common congenital brain disorder
10. New clues to hereditary blinding disease found
11. Anti-bacterial additive found in Maryland streams

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2019)... ... , ... ActX has launched a medical genetic interpretation ... can get access to professionally reviewed genetic screening similar to what a physician ... + Ancestry customers., With the ActX + 23andMe service, both 23andMe customers and ...
(Date:6/24/2019)... ... , ... According to the World Health Organization , over a million ... gonorrhea, trichomoniasis (or "trich") and syphilis. And that’s not counting HIV. , In ... for the largest number of HIV diagnoses (9,807), followed by Hispanic/Latino men (7,436) and ...
(Date:6/20/2019)... ... June 19, 2019 , ... ... Infectious Diseases Society of America Foundation, and the possibly millions of dollars of ... infectious agents in AD, are a “welcome affirmation” of the need to investigate ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... ... Alice Branton today released research results from preclinical trials on the beneficial ... prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... , Over 142% increase in particle size , Over 3% ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... IND is the first of several planned clinical trials which will enable qualified PSC-enrolled ...
(Date:6/12/2019)... (PRWEB) , ... June 12, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... Zillion has been signed. The agreement will grant exclusive rights for Zillion to ...
Breaking Biology Technology:
Cached News: